Electroconvulsive therapy is the most effective treatment for severe depression and several other psychiatric emergencies. The public image of ECT — formed largely by mid-twentieth century portrayals — bears little resemblance to the modern procedure. The actual ECT experience is calm, brief, and dignified, performed under general anesthesia with muscle relaxation, with response rates that outperform any medication in severe cases.
- Class
- Brain stimulation procedure
- Mechanism
- Brief electrical pulses induce generalized seizure (~30-60 seconds) under anesthesia. Mechanism not fully understood — likely involves neurotransmitter changes, neuroplasticity (BDNF, neurogenesis), normalization of dysregulated networks (DMN, salience).
- Typical dose
- Acute course typically 6-12 treatments (3x/week). Maintenance ECT (weekly to monthly) for some patients.
- FDA indications
- Severe major depression (especially with psychotic features, suicidality, catatonia, refusing to eat), treatment-resistant depression, severe bipolar depression and mania, catatonia, severe schizophrenia, NMS (rare)
- Key adverse effects
- Short-term memory impairment (typically resolves over weeks), anesthesia risks, headache, muscle soreness, transient confusion. Bilateral ECT more memory effects than right unilateral.
Most effective treatment for severe depression — 60-80% response rates. Public stigma exceeds actual risk profile (modern ECT is safe). Modern technique: brief-pulse stimulator, right unilateral or bifrontal placement (less memory impact), general anesthesia with muscle relaxation. Maintenance ECT prevents relapse in some patients.
Modern technique: brief-pulse stimulator (replacing the older sine-wave devices), right-unilateral or bifrontal electrode placement (much better memory preservation than bilateral), general anesthesia with muscle relaxation (essentially no visible motor activity during the seizure). The seizure itself lasts 30-60 seconds; the procedure including pre-op and recovery is typically 30-45 minutes. Patients return to baseline within hours.
ECT remains the most effective treatment in psychiatry — a controlled, generalized seizure that produces broad neuroplastic and neurochemical effects no medication matches.
Mechanism note: ECT is the most effective psychiatric treatment — fast, broad, and the right choice for the most severe and dangerous presentations; modern technique tames the cognitive cost, and continuation treatment prevents relapse.
Acute course: typically 6-12 treatments over 2-4 weeks, three times per week. Substantial response often appears within the first week. Some patients then transition to maintenance ECT (weekly to monthly) to prevent relapse; others transition back to pharmacotherapy after the acute course.
- Cost
- Per-treatment ~$1,500-3,000+ including anesthesia, professional fees, facility. Course of 8-12 treatments substantial.
- Generic status
- Procedure, not medication.
- Formulary typical
- Medicare covers. Most commercial insurance covers for FDA indications. PA typical for outpatient courses.
- Access friction
- Specialized ECT-equipped facility required. Anesthesia services. Patient transportation (no driving same day). Stigma still affects patient acceptance and sometimes referral.
Prescriber tip: For severe treatment-resistant or acute illness, ECT is often the most effective option. Refer to specialty ECT services; document failed prior treatments for PA.
Indications: severe major depression — especially with psychotic features, suicidality, food refusal, or treatment resistance — is the most common. Catatonia where lorazepam is insufficient. Severe mania. Severe bipolar depression. Selected schizophrenia cases. NMS (rare). The common thread: severe, acute, treatment-resistant or treatment-urgent psychiatric illness where time matters.
Memory effects are the main side effect concern. Anterograde memory difficulties during and shortly after the course are common but typically resolve over weeks. Some retrograde memory for events around the treatment period may not return — patients may have permanent gaps for recent days or weeks. Right-unilateral electrode placement reduces memory effects substantially compared to bilateral. The newer ultrabrief pulse techniques further reduce memory impact.
Underutilization is real. Stigma still affects who gets ECT. Many patients who would benefit don't receive it, sometimes because the conversation never happens. For the patient with severe treatment-resistant depression with suicidality, ECT is the most effective option; the conversation should happen.